Event Format



Thu, Jun 13, 2024, 12:00 PM – Thu, Jun 13, 2024, 01:00 PM




Sponsored Webinars

Event Host

Contact Information

Brooke Akins
(312) 895-2547


Foundation Frontiers: A Medical Education Webinar   
Fusion Detection in Advanced Non-Small Cell Lung Cancer: Stay up to Date

Thursday, June 13, 2024 
1 - 2 p.m. Eastern; noon - 1 p.m. Central; 10 - 11 a.m. Pacific

In non-small cell lung cancer (NSCLC), targetable driver alterations include ALK*, RET**, and ROS1*** fusions. DNA-based and RNA-based next-generation sequencing each have advantages and drawbacks for detecting gene fusions. In this webinar, expert speakers will present their perspectives on fusion detection in NSCLC.  

Attendees Will Learn:

  • Summary of currently approved therapies for fusions in NSCLC.  
  • Methods and recommendations for fusion detection with comprehensive genomic profiling. 
  • The pros and cons of DNA and RNA sequencing for fusion detection.  
  • About fusion detection in the context of a hypothetical patient case.   


Mark Socinski, MD  
Executive Director (Thoracic Cancer), Medical Oncologist   
AdventHealth Cancer Institute  
Orlando, FL  

Holli Dilks, PhD  
Senior Director, Global Head of Field Medical 
Foundation Medicine  
Boston, MA

* Anaplastic lymphoma kinase (ALK) 
** rearranged during transfection (RET) 
*** ROS proto-oncogene 1, receptor tyrosine kinase (ROS1) 

Sponsored By